Table 3.
Endpoints, no of patients (%) (N = 181)
| Mortality overall 24 h | 13 (7.2%) |
| Mortality 24 h > 500 mL bleeding * | 12 (12.1%) |
| Shock Index > 1.3 | 59 (32.6%) |
| Coagulopathy overall | 75 (41.4%) |
| PT-INR > 1.2 | 14 (7.7%) |
| Platelet count < 150 × 109/L | 9 (5.0%) |
| aPTT > 32 s | 16 (8.8%) |
| PT-INR > 1.2 and Platelet count < 150 × 109/L | 4 (2.2%) |
| PT-INR > 1.2 and aPTT > 32 s | 19 (10.5%) |
| Platelet count < 150 × 109/L and aPTT > 32 s | 3 (1.7%) |
| PT-INR > 1.2 and Platelet count < 150 × 109/L and aPTT > 32 s | 10 (5.5%) |
*Data is presented for 99 patients who all had a bleeding more than 500 mL